10:48 AM
Nov 13, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Liver fibrosis

Patient sample and mouse studies suggest antagonizing AHR or RORγT could help treat liver fibrosis. In liver tissue samples from hepatitis patients, levels of IL-17A and IL-22, which are positively regulated by AHR and RORγT, respectively, were higher...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >